BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Renewed Contract: MRIGlobal Awarded $19.9 Million NIH Contract To Operate Chemopreventive Agent Repository For National Cancer Institute

  MRIGlobal has been awarded a 5-year, $19.9 million contract from the National Institutes of Health (NIH)/National Cancer Institute (NCI)/Division of Cancer Prevention to continue to operate the Centralized Chemopreventive Agent Repository and Drug Chemistry Support program.

  August 8, 2018

   · 

  2 min read
• Business

  Egalet Reports Second Quarter 2018 Financial Results

  Improvements in formulary status for key products

  August 8, 2018

   · 

  21 min read
• Business

  TIENS Group opens new high-tech Experience Store in Shenzhen

  TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen.

  August 8, 2018

   · 

  2 min read
• Business

  Axsome Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update

  Interim analysis results from two Phase 3 trials and topline results from one Phase 2 trial of AXS-05 anticipated in 4Q 2018

  August 8, 2018

   · 

  13 min read
• Business

  ProQR Announces Financial Results for the Second Quarter of 2018

  Initiated WINGS, the first clinical trial to evaluate the safety and efficacy of QR-313 in patients that have recessive dystrophic epidermolysis bullosa (RDEB) due to mutations in exon 73 of the COL7A1 gene

  August 8, 2018

   · 

  12 min read
• Business

  Novanta Announces Financial Results for the Second Quarter 2018

  Second Quarter 2018 GAAP Revenue of $150.4 million, up 26% year over year

  August 8, 2018

   · 

  57 min read
• Business

  Paragon Bioservices Announces Two Key Leadership Promotions

  Paragon Bioservices announces two key leadership promotions.

  August 8, 2018

   · 

  3 min read
• Pharm Country

  Realm Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

  Realm Therapeutics plc announces that Alex Martin, CEO, will be presenting at the 2018 Wedbush PacGrow Healthcare Conference, on Tuesday, August 14, 2018 at 4:15 p.m. ET at the Parker New York.

  August 8, 2018

   · 

  1 min read
• Deals

  AcelRx Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

  AcelRx Pharmaceuticals, Inc. announced that the underwriters of its previously announced underwritten public offering have exercised in full their option to purchase an additional 1,090,909 shares of AcelRx’s common stock.

  August 8, 2018

   · 

  2 min read
• Business

  Context Therapeutics Signs Strategic Research Collaborations for Apristor® (onapristone extended release) With Key Academic Leaders in the Progesterone Receptor (PR) and Breast Cancer Fields

  Context Therapeutics today announces it has signed multiple research collaborations to further understand the role of progesterone receptor (PR) signaling.

  August 8, 2018

   · 

  4 min read